BlogHotel.orgAccueil | Créer un blog | Imprimer la page Imprimer | Blog hasard Au hasard | Chercher des blogs Rechercher | Entrer dans le chat du blog Chat | | Jeux Jeux | Adminitration et édition du Blog Manager

shinenewstop Accueil | Profil | Archives | Amis
shinenewstop

Nootropics Powder 99% Compound 7p CAS 1890208-58-8! ! ! 14/10/2019

Compound 7p was developed as one in series of compounds with the aim of identifying dual-acting thromboxane receptor antagonist/synthase inhibitors . In fact compound 7p

shows selectivity for prostaglandin I2 synthase (PTGIS , CYP8A1) over thromboxane synthase (CYP5A1) .Compound 7P
Product Name: Compound 7P
Chemical Name: 2-[(2-methoxyphenyl)[(4-methylphenyl)sulfonyl]amino]-N-(4-methoxy-3-pyridinyl)acetamide ;2-(N-(2-methoxyphenyl)-4-methylphenylsulfonamido)-N-(4-

methoxypyridin-3-yl)acetamide
CAS No.: 1890208-58-8
Reaxys Registry Number: 29568294
Molecular Formula: C22H23N3O5S
Molecular Weight: 441.508
Density(Predicted): 1.329±0.06 g/cm3 |Condition:Temp:20 Press:760Torr

Compound 7p was developed as one in series of compounds with the aim of identifying dual-acting thromboxane receptor antagonist/synthase inhibitors . In fact compound 7p

shows selectivity for prostaglandin I2 synthase (PTGIS , CYP8A1) over thromboxane synthase (CYP5A1) .
Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential, and one of the

strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways .

Nootropics Powder 99% Compound 7p CAS 1890208-58-8! ! !
Compound 7p was developed as one in series of compounds with the aim of identifying dual-acting thromboxane receptor antagonist/synthase inhibitors . In fact compound 7p

shows selectivity for prostaglandin I2 synthase (PTGIS , CYP8A1) over thromboxane synthase (CYP5A1) .

Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential, and one of the

strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways .
Here we report phenotypic cell-based screen of chemical libraries and structure-activity-guided optimization that resulted in the identification of compound 7p which promotes

neurite outgrowth of cultured primary neurons derived from the hippocampus, cerebral cortex, and retina .

In an animal model of optic nerve injury, compound 7p was shown to induce growth of GAP-43 positive axons, indicating that the in vitro neurite outgrowth activity of compound 7p

translates into stimulation of axon regeneration in vivo. Further optimization of compound 7p and elucidation of the mechanisms by which it elicits axon regeneration in vivo will

provide a rational basis for future efforts to enhance treatment strategies .

Poster un Commentaire

Entry 4214 of 5390
Précédent | Suivant

Blog suivant >> Signaler un abus? Haut de page